PARACETAMOL EVOLUGEN PHARMA (paracetamol) - Pain and/or fever
Opinions on drugs -
Posted on
Jul 01 2024
Reason for request
First listing
Summary of opinion.
Favourable opinion for reimbursement in the symptomatic treatment of mild to moderate pain and/or fever.
Clinical Benefit
Substantial |
The Committee issues a favourable opinion for inclusion in both the list of covered drugs for outpatients and the list of covered drugs for inpatients approved for use in the indication and at the MA dosages. |
Clinical Added Value
no clinical added value |
These medicinal products are a range supplement that do not provide any clinical added value (CAV V) compared to the forms already listed. |
English version
Contact Us
Évaluation des médicaments